v3.25.1
Stockholders' Equity (Deficit) (Tables)
3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Loss
The following table shows the components of accumulated other comprehensive loss, net of income taxes, (“AOCI”) in the stockholders’ equity section of our condensed consolidated balance sheets at the dates indicated (in thousands):
March 31, 2025December 31, 2024
Unrealized foreign currency translation adjustment, net of realized amounts reclassified into loss from divestitures of businesses$(18,193)$(26,172)
Unrealized translation losses on intercompany loans with foreign subsidiaries, net of taxes(4,979)(6,477)
Unrealized gains on interest rate swaps, net of amounts reclassified into interest expense, net6,590 9,033 
Realized gain on interest rate swap sale, net of amounts reclassified into interest expense, net179 1,626 
Total accumulated other comprehensive loss$(16,403)$(21,990)
Schedule of PRSU Activity
The following table summarizes PSU and RSU activity during the three months ended March 31, 2025:
Number of UnitsWeighted-Average Grant Date Fair Value
Unvested restricted units outstanding as of December 31, 20242,277,132 $5.36 
Granted1,455,000 5.88 
Vested(475,744)5.17 
Forfeited(227,210)4.51 
Unvested restricted units outstanding as of March 31, 20253,029,178 $5.70 
Schedule of RSU activity
The following table summarizes PSU and RSU activity during the three months ended March 31, 2025:
Number of UnitsWeighted-Average Grant Date Fair Value
Unvested restricted units outstanding as of December 31, 20242,277,132 $5.36 
Granted1,455,000 5.88 
Vested(475,744)5.17 
Forfeited(227,210)4.51 
Unvested restricted units outstanding as of March 31, 20253,029,178 $5.70 
Schedule of Valuation Assumptions
The significant assumptions used in the Monte Carlo simulation model for the PSUs granted during the three months ended March 31, 2025 was as follows:
Expected volatility
81.9%
Risk-free interest rate
4.2%
Remaining performance period (in years)
 3.08
Dividend yield
Schedule of Allocated Share-Based Compensation Expense
The Company recognizes stock-based compensation expense from all awards in the following expense categories included in our condensed consolidated statements of income (in thousands):
Three Months Ended March 31,
20252024
Cost of revenue$121 $186 
Research and development290 606 
Sales and marketing252 397 
General and administrative2,012 2,333 
Total$2,675 $3,522